Introduction. This study addressed the role of the local renin-angiotensin system (RAS) , n=36) or high salt diet (1% NaCl, n=38) were trained by two protocols (T1: 60-min swimming session, 5 days per week for 10 weeks and T2: the same T1 protocol until the 8 th week, then 9 th week they trained twice a day and 10 th week they trained three times a day). Salt loading prevented activation of the systemic RAS. Haemodynamic parameters, soleus citrate synthase (SCS) activity and LVH (left ventricular/body weight ratio, mg/g) were evaluated. Results. Resting heart rate decreased in all trained groups. SCS activity increased 41% and 106% in T1 and T2 groups, respectively. LVH was 20% and 30% in T1 and T2 groups, respectively. Enalapril prevented 39% of the LVH in T2 group (p<0.05). Losartan prevented 41% in T1 and 50% in T2 (p<0.05) of the LVH in trained groups. Plasma renin activity (PRA) was inhibited in all salt groups and it was increased in T2 group. Conclusions. These data provide evidence that the physiological LVH induced by swimming training is regulated by local RAS independent from the systemic, because the hypertrophic response was maintained even when PRA was inhibited by chronic salt loading. However, other systems can contribute to this process.
Introduction
The renin-angiotensin system (RAS) is recognised as an important systemic hormonal regulator of cardiovascular homeostatic mechanism. However, this idea has been modified because several components of the RAS and their mRNAs have been found in different tissues leading to the concept of local tissue RAS. 1 All components of the RAS have been identified in the heart (angiotensinogen, renin, angiotensin-converting enzyme (ACE) and angiotensin II (Ang II) receptors), both at mRNA and at protein level. 1 Previous reports suggested that the cardiac RAS is activated by several hypertrophic stimuli such as pressure overload, sympathetic stimulation or heart failure, 2 and that sub pressor doses of ACE inhibitors or Ang II type 1 (AT 1 )-receptor blockers can cause regression of cardiac hypertrophy independently of the reduced systolic blood pressure. 3, 4 Also, biomechanical stress can be transduced to intracellular signalling and induces cardiac hypertrophy by AT 1 -receptors. 5 These findings suggest that the local RAS may play an important role in the genesis of the cardiac hypertrophy.
Under pathological conditions, such as arterial hypertension and aortic stenosis, the chronic left ventricular pressure overload is an important stimulus for left ventricular hypertrophy (LVH). The tissue RAS, mainly Ang II, plays an important role in the ventricular remodelling process promoting cardiomyocyte hypertrophy, myocardial fibrosis 6 and consequently ventricular dysfunction. Conversely, in endurance athletes, an increased cardiac wall tension due to the combined increased pressure and volume during physical exercise seems to be an important stimulus for physiological LVH. 7 However, athletes usually show normal diastolic filling patterns, suggesting no changes in the myocardial (compliance) connective tissue.
Regarding the ACE gene, the insertion (I) or deletion (D) polymorphism in the gene encoding ACE has been associated with differences in the plasma levels of ACE as well as cardiac ACE activity. 8 The absence (D) of a 287-base pair marker in the ACE gene is associated with higher ACE levels than its presence (I). Results from athletes show that exercise-related left ventricle (LV) growth might be influenced by ACE genotype. 9 Montgomery et al. 10 reported that LV mass increases more in DD athletes versus II after 10 weeks of endurance training. The role of RAS in the physiological hypertrophy development has also been confirmed by other groups. 11, 12 These data suggest that cardiac RAS might be an important regulator of myocardial growth in response to a physiological hypertrophic stimulus such as the physical training.
The present study was designed to address the role of the RAS in the cardiac hypertrophy induced by physical training by investigating the local and systemic RAS participation in the physiological hypertrophy induced by swimming training, using two very well-controlled training protocols.
Materials and methods

Animal care
Female normotensive Wistar rats (190 to 220 g, n=112) were used and handled according to approved institutional guidelines. The animals were housed 3-5 per cage in a controlled room temperature (22 o C) with a 12-h dark-light cycle and fed standard rat chow having access to water or drug treatment ad libitum. All protocols and surgical procedures used were in accordance with the guidelines of the Brazilian College for Animal Experimentation and were approved by the Ethics Committee of the School of Physical Education and Sport of the University of São Paulo.
The rats were randomly assigned into three experimental groups. Group 1 (ACE inhibitor (ACE-I), n=38): treated with enalapril maleate, 60 mg.kg -1 . d -1 as drinking water. Group 2 (AT 1 -receptor blocker Los, n=36): treated with losartan, 20 mg. kg -1 .d -1 as drinking water. Group 3 (Salt, n=38): chronic salt loading treatment (1% NaCl was added to drinking water). These oral doses of ACE-I and AT 1 -receptor blocker were chosen because they do not lower blood pressure in normotensive rats, 13, 14 while high salt diet was used to inhibit the systemic RAS due to decrease in the renin release.
14 The treatments began on the same day as the exercise training and continued thereafter.
Swimming training was performed according to two protocols described below, designated T1 and T2.
Exercise training protocols and experimental groups Protocol 1 (T1): Swimming sessions of 60-min duration, 5 days a week, for 10 weeks.
Protocol 2 (T2): This protocol began two weeks before T1. Animals assigned to T2 performed a swimming training protocol similar to protocol T1 until the end of the 8 th week. On the 9 th week, they trained twice a day, swimming sessions of 60-min duration with a 6-h interval between each session. On the 10 th week, they trained three times a day, having swimming sessions of 60-min duration with a 4-h interval between each session. The aim of increasing training frequency (protocol T2) was to induce robust cardiac hypertrophy.
Group 1 (n=38) was subdivided into six subgroups: sedentary (S, n=6), sedentary treated with enalapril (S-ACE-I, n=6), swimming trained following protocol 1 (T1, n=7), swimming trained following protocol 1 and treated with enalapril (T1-ACE-I, n=6), swimming trained following protocol 2 (T2, n=7), swimming trained following protocol 2 and treated with enalapril (T2-ACE-I, n=6).
Group 2 (n=36) was subdivided into six subgroups: sedentary (S, n=6), sedentary treated with losartan (S-Los, n=6), swimming trained following protocol 1 (T1, n=6), swimming trained following protocol 1 and treated with losartan (T1-Los, n=6), swimming trained following protocol 2 (T2, n=6), swimming trained following protocol 2 and treated with losartan (T2-Los, n=6). Group 3 (n=38) was subdivided into six subgroups: sedentary (S, n=7), sedentary treated with high salt diet (S-Salt, n=7), swimming trained following protocol 1 (T1, n=6), swimming trained following protocol 1 and treated with high salt diet (T1-Salt, n=6), swimming trained following protocol 2 (T2, n=6), swimming trained following protocol 2 and treated with high salt diet (T2-Salt, n=6). This protocol with chronic salt loading was used only to uncouple local versus systemic activation of the RAS due to plasma renin activity (PRA) inhibition. 14, 15 It should be noted that each experimental group had a different sedentary group. This was necessary because, due to the high number of animals used, not all training groups could be performed at the same time.
Animals were trained in a swimming apparatus specially designed to allow individual exercise training of rats similar to the one described and illustrated for mice. 16 The apparatus consisted of Exercise duration and workload were increased gradually until rats could swim for 60 min wearing caudal dumbbells weighing 5% of their body weight. Thereafter, duration and dumbbells were kept constant. It has been estimated that a rat swimming alone consumes O 2 at 50-65% of its maximum capacity. 17 All animals were weighed once a week and the workload adjusted to 5% of body weight. This swimming protocol has been characterised previously as low to moderate intensity and long duration due to improvement in muscle oxidative capacity. 18 Sedentary groups were placed in the swimming apparatus for 10 min twice a week without workload to mimic the water stress associated with the experimental protocol.
Haemodynamic parameters
Tail-cuff systolic blood pressure was measured in the three experimental groups twice a week during the first two weeks, using a tail-cuff plethysmograph (Kent Scientific). Systolic blood pressure did not reduce among the treated groups of animals compared to the non-treated groups (data not shown).
Twenty-four hours after the last training session, under anaesthesia (ketamine 90 mg.kg -1 and xylasine 10 mg.kg -1 , i.p.) a cannula (PE-50) was inserted into the carotid artery and emerged through the back of the rat's neck. Twenty-four hours after implantation, the cannula was connected to a strain-gauge transducer (P23 Db; Gould-Statham) and systolic, diastolic and mean arterial pressure were recorded on a beat to beat basis (AT/CODAS) at a frequency of 1,000 Hz for 30 min in quiet, conscious, unrestrained rats. Heart rate was obtained from arterial blood pressure pulses.
At the end of the experimental period, the rats were killed by quick decapitation without prior anaesthesia and blood and soleus muscle samples were harvested, frozen and stored at -80 o C. To determine PRA, the first 3 ml of trunk blood (a mixture of venous and arterial blood) was rapidly collected in chilled glass tubes containing a mixture of potassium EDTA (25 mmol), o-phenanthroline (0.44 mmol), pepstatin A (0.12 mmol), and 4-(chloromercuribenzoic acid) (1 mmol). This mixture of protease inhibitors prevented the in vitro production and degradation of angiotensin peptides. 19 The blood was centrifuged, the plasma was separated and stored at -20 o C. In addition, the heart was harvested and weighed.
Measurement of cardiac hypertrophy
To measure cardiac mass, the LV was dissected corresponding to the remaining tissue upon removal of both atria (AT) and the free wall of the right ventricle (RV). The interventricular septum remained as part of the LV. The cardiac hypertrophy was assessed by the measurement of the ratio of LV, RV and AT weight (W) in milligrams to animal body weight (BW) in grams (LVW/BW, RVW/BW and ATW/BW in mg.g -1 ).
PRA assay
The PRA was measured by angiotensin I radioimmunoassay, using a commercially available kit (REN-CT2, CIS Bio International, Gif-sur-Yvette, France). This assay permits direct measurement of PRA. Results were quantified in a gamma counter, and the enzyme activity was expressed as ng AI.ml
. This assay was only performed in T1 and T2 training protocols to observe the PRA modulation by the exercise training, and in salt loading groups to confirm the inhibition of PRA.
Citrate synthase activity measurement
Citrate synthase activity was determined spectrophotometrically in mixed right soleus according to the method of Srere 20 and used as a marker of muscle oxidative activity. The enzyme activity was measured in whole muscle homogenates of sedentary (n=7), T1 (n=8) and T2 (n=8) groups, and the amount of the complex resulting from acetyl-CoA and oxaloacetate was determined at 412 nm and 25 o C, at an interval of 10 min. Citrate synthase activity was expressed as µmol.ml .mg -1 of protein and was only measured in these groups to show the effectiveness of the swimming training protocols and show that the increased frequency of swimming training leads to significant endurance conditioning.
Protein determination
Protein was measured by the method of Bradford 21 using bovine serum albumin as a standard. 
Statistical analysis
Results are represented as mean±standard deviation (SD). Statistical analysis was performed using randomised two-way ANOVA, except for citrate synthase activity when one-way ANOVA was used. P values <0.05 were accepted as statistically significant. Tukey's post hoc test was used for individual comparisons between means when a significant change was observed with ANOVA. Table 1 summarises systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood pressure (MBP) and heart rate (HR) measured at the time prior to sacrifice, 48 h after the last session of swimming training of groups 1, 2 and 3. There was no difference of blood pressure among sub-groups that were treated with different inhibitors. However, HR decreased significantly after 10 weeks of swimming training in T1 and T2 groups compared to their respective controls. In addition, the T2-ACE-I and T2-Salt showed a larger reduction in HR. The HR in T2-ACE-I was reduced compared to sedentary, S-ACE-I and T1-ACE-I groups. The HR in T2-Salt was reduced compared to sedentary, S-Salt, T1-Salt and T2 groups. Neither enalapril, losartan nor salt alone altered HR. The development of resting bradycardia in the trained animals indicates that aerobic conditioning was achieved with these two training protocols.
Results
Haemodynamic parameters
Citrate synthase activity
One of the hallmarks of skeletal muscle adaptation to aerobic conditioning is the increase in muscle oxidative activity concomitant with an increase in aerobic work capacity. ).
Cardiac hypertrophy BW before and after swimming training was similar among all the studied groups ( gain of RV was less pronounced than that of the LV in both T1 and T2 training protocols, the percentage of weight gain in the LV and the RV was proportional to both ventricles, suggesting that hypertrophy was developing symmetrically. Figure 1A shows the effects of the specific ACE-I (enalapril) in LVH induced by swimming training and its association to the different training protocols. Both T1 and T2 training protocols induced significant LVH (20% and 31%, respectively; p<0.001) compared with the sedentary. The LVH for both T1-ACE-I and T2-ACE-I was 10% (p>0.05) and 22% (p<0.05), respectively, compared with sedentary. Collectively, these results indicate that the drug was able to prevent, at least partially, swimming training-induced cardiac hypertrophy in T1-ACE-I group (because T1-ACE-I group was not different when compared with T1 group) and in T2-ACE-I group (because T2-ACE-I group was different compared with the S-ACE-I group). There was no significant difference between S-ACE-I and sedentary groups. Figure 1B shows the effects of the AT 1 -receptor blocker (losartan) on the LVH induced by swimming training and its association to the LVH induced by the different training protocols. Both T1 and T2 training protocols induced significant LVH similar to that observed in the enalapriltreated group (17% and 28%, respectively; p<0.05) compared with the sedentary. The LVH at both T1-Los and T2-Los was maintained at 5% and 8% (both p>0.05), respectively, compared with S-Los. The results indicate that the treatment was able to prevent totally, in T1-Los and T2-Los groups, the swimming training-induced LVH (figure 1B;  table 2 ). There was no difference between S-Los and sedentary.
Chronic salt loading was used only to uncouple local versus systemic activation of the RAS. The swimming training resulted in activation of PRA only in the T2 training protocol (4.33±1.10 ng AngI.ml ) trained groups ( figure  2A ). Figure 2B shows the effects of the swimming training on LVH and the association of chronic salt loading on cardiac hypertrophy induced by T1 and T2 training protocols. Both T1 and T2 training protocols induced significant LVH, similar to that observed in the enalapril-and losartan-treated groups (22% and 32%, respectively; p<0.001) compared with the sedentary. The high salt diet in both T1 and T2 trained groups increased LVH significantly (21% and 26%, respectively; p<0.001) compared with the S-Salt, indicating that the plasma RAS inhibition was not able to prevent the cardiac hypertrophy induced by swimming training. Salt loading produced a slight, but significant, hypertrophy when compared to the sedentary group (8%; p<0.05).
Discussion
Our results, demonstrating that LVH was not decreased when the systemic RAS was inhibited by chronic salt treatment, show that the LVH induced by swimming training depends on the local RAS activity (as shown by losartan and enalapril treatment) instead of the systemic RAS. This is the first report of a detailed study that has been performed to investigate the participation of the local versus systemic RAS in the cardiac hypertrophy induced by aerobic exercise training.
There are many data in the literature that support the role of the RAS in the development of cardiac hypertrophy in many pathological states. We have also provided here evidence for a role for RAS in the physiological hypertrophy. Our results are in agreement with those of Iemitsu et al., 22 which show that both forms of cardiac hypertrophy may share some of the same molecular mechanisms.
Physical conditioning markers
The training protocols were designed to obtain different magnitudes of cardiac hypertrophy to study the systemic and local RAS participation in the mechanisms of swimming-induced physiological hypertrophy. In this study, two training markers were used to show that the animals were trained. Concerning the cardiovascular effects, resting bradycardia has been considered the hallmark of the aerobic exercise training adaptation. 16, 18 The swimming trained groups showed a lower resting HR when compared to the sedentary. The magnitude of resting bradycardia was even larger in the T2 groups.
Also, the increase in skeletal muscle oxidative capacity by exercise training is a well-established adaptation, 16, 18 and is also considered a good metabolic marker for exercise training efficiency. Citrate synthase activity was measured in mixed soleus muscle of rats. The enzyme activity increased significantly, 41% and 106% in T1 and T2 groups, respectively, compared with the sedentary. These results show the effectiveness of the swimming training protocols and show that the increased frequency swimming training leads to significant endurance conditioning.
In addition, there were no differences in SBP, DBP and MBP among groups, after swimming training. This finding is in accordance with previous reports from our group 16, 18, 23 and others, 10, 24 showing that arterial pressure remains unchanged in exercisetrained normotensive animals and humans. 
Cardiac hypertrophy and RAS
Although physiological stimulus, such as exercise training, results in cardiac hypertrophy, only a few reports have investigated the role of RAS in this process. 9, 23, 25 Previous results and the ones presented here clearly demonstrate that swimming training leads to cardiac hypertrophy, 18, 25, 26 and the magnitude is influenced by endurance conditioning. 16, 27 LVH increased by 20% in the T1; however, T2 group increased 50% more than observed by T1 group. RVH increased by 10% to 23% in the T1 to T2 group. The results confirm what Bjornstad et al. 28 described with athletic students and sedentary controls, that RVH is a normal characteristic in the heart of trained healthy subjects.
RAS blockade by ACE inhibition
Enalapril is a well-known ACE-I used for the treatment of hypertension and heart failure. 4 Our findings show that the treatment with enalapril at a dose that did not decrease blood pressure, partially, attenuated cardiac hypertrophy estimated by the ratio of LVW to BW. Regarding the percentage of LVH in each group, the enalapril treatment did not completely prevent cardiac hypertrophy in T1, but attenuated it by 39% in T2 trained groups. However, the hypertrophy of T2-ACE-I group was still increased when compared with the S-ACE-I group. Since the cardiac hypertrophy was not completely blocked by ACE-I, we cannot discard the hypothesis that cardiac hypertrophy might be influenced by other alternative enzymatic pathways of Ang II formation independent of ACE activity, such as chymase. 29 Besides, the AT 1 -receptor can be activated by mechanical stress through an Ang II-independent mechanism. 5 There are also other non-Ang II mechanisms of physiological hypertrophy that could still be activated even with RAS blockade to explain the residual cardiac hypertrophy observed, such as intracellular phosphoinositide-3-kinase pathway through the insulin-like growth factor 1 receptor 30 and kinin B 2 receptor. 
RAS blockade by Ang II receptor antagonism
Several studies have focused on the effect of Ang II receptor blockers on the development of pressure-overload hypertrophy. It prevents LVH and reduces the stretch-induced hypertrophic response in cardiac myocytes. 6, 32 In the present study, the losartan treatment was able to prevent 41% of the cardiac hypertrophy in T1 and 50% in T2 trained groups. Therefore, the T1-Los and T2-Los groups were not different when compared with sedentary and S-Los groups.
These results show that the AT 1 -receptor blocker was more effective than the specific ACE-I to prevent the cardiac hypertrophy induced by swimming training. These data are not in agreement with those previously reported in the literature. Greenen et al. 25 showed that L-158,809, a non-peptide AT 1 -receptor selective blocker, does not prevent physiological cardiac hypertrophy induced by swimming training in adult rats. However, the drug was administered as a subcutaneous bolus of 10 mg/kg twice per week with an interval of 72 and 96 h between each injection. As the half-life of this drug in rats' plasma is 7.6±3.1 h, 33 there is the possibility that the local system was not totally inhibited.
Dissociation of RAS local versus systemic by chronic salt loading
Different from what has been previously shown, 9, 25 we were able to demonstrate the association of LVH induced by swimming training and local activation of RAS, even when PRA was suppressed by chronic salt loading. This manoeuvre led to the inhibition of the systemic RAS and prevented exercise training from causing the expected induction of renin release. Swimming training resulted in activation of PRA. Nevertheless, it was only significant for the T2 training protocol, where the frequency of swimming training was increased. Our observations are consistent with those reported in the literature that show PRA significantly increased after graded workload. 34, 35 On the other hand, the concentration of sodium may modulate cardiac mass. 36, 37 LV mass increased 8% when the sodium salt diet was administrated alone compared to sedentary controls. These findings are also consistent with those reported in the literature that show that dietary salt is able to increase heart weight despite the lack of an increase in blood pressure, 38, 39 however, upregulate the AT 1 -receptor, 37 and thus this might be the mechanism of the induced cardiac hypertrophy. Our findings show that LVH increased by 22% to 31% in the T1 to T1-Salt and increased by 32% to 36% in the T2 to T2-Salt groups when the hypertrophy was initially compared to sedentary group. Therefore, cardiac hypertrophy observed in the T1 and T2-Salt groups added approximately the same value observed for the sodium salt diet alone. The effects of these two procedures were additive. Similar results were observed to RV. Swimming training induced LVH even when the PRA was suppressed by chronic salt loading diet (T1 and T2 plus salt groups), suggesting the dissociation between systemic and local activation of the RAS by exercise training. A previous report, using bilateral nephrectomy, has also suggested that the local RAS can be regulated independently from the systemic RAS and may contribute to the cardiac hypertrophic response. 40 
Conclusions
Taken together, our results demonstrate that the two aerobic swimming training protocols used induce different magnitudes of cardiac hypertrophy. Using the specific inhibitors enalapril and losartan, we demonstrated that the RAS has a key role in exercise-induced cardiac hypertrophy. Using chronic salt loading treatment, we demonstrated that swimming-induced physiological hypertrophy is locally regulated and independent from the systemic RAS. 
